blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1280817

EP1280817 - PRODUCTION AND USE OF PROTEIN VARIANTS HAVING MODIFIED IMMUNOGENECITY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.03.2007
Database last updated on 09.09.2024
Most recent event   Tooltip02.03.2007Application deemed to be withdrawnpublished on 04.04.2007  [2007/14]
Applicant(s)For all designated states
Novozymes A/S
Krogsho̸jvej 36
2880 Bagsvaerd / DK
[N/P]
Former [2003/06]For all designated states
Novozymes A/S
Krogshoejvej 36
2880 Bagsvaerd / DK
Inventor(s)01 / ROGGEN, Erwin, Ludo
Asavaenget 14
DK-2800 Lyngby / DK
02 / ERNST, Steffen
Edelsmindevej 18
DK-2700 Bronshoj / DK
03 / SVENDSEN, Allan
Overdamsvej 13
DK-2970 Horsholm / DK
04 / FRIIS, Esben, Peter
Langagervej 15, 2. tv.
DK-2500 Valby / DK
05 / VON DER OSTEN, Claus
Christian Winthers Vej 15
DK-2800 Lyngby / DK
 [2003/06]
Application number, filing date01927643.530.04.2001
[2003/06]
WO2001DK00293
Priority number, dateDK2000000070728.04.2000         Original published format: DK 200000707
DK2001000032728.02.2001         Original published format: DK 200100327
[2003/06]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0183559
Date:08.11.2001
Language:EN
[2001/45]
Type: A2 Application without search report 
No.:EP1280817
Date:05.02.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 08.11.2001 takes the place of the publication of the European patent application.
[2003/06]
Search report(s)International search report - published on:EP20.06.2002
ClassificationIPC:C07K1/00, C12N9/00, C07K16/00, C07K14/00, G01N33/53, G06F17/50
[2003/06]
CPC:
C12N9/54 (EP,US); A21D2/267 (EP,US); A21D8/042 (EP,US);
C07K1/047 (EP,US); C07K14/001 (EP,US); C07K16/40 (EP,US);
C07K16/4283 (EP,US); C07K5/1008 (EP,US); C07K5/101 (EP,US);
C07K5/1013 (EP,US); C07K5/1019 (EP,US); C07K5/1021 (EP,US);
C11D3/38627 (EP,US); C11D3/38645 (EP,US); C12N9/0061 (EP,US);
C12N9/20 (EP,US); C12Y110/03002 (EP,US); A61K39/00 (EP,US);
C12Y304/21062 (EP,US); Y10S435/911 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/06]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:IDENTIFIZIERUNG, PRODUKTION UND VERWENDUNG VON PROTEINVARIANTEN MIT VERÄNDERTEN IMMUNOGENZITÄT[2003/06]
English:PRODUCTION AND USE OF PROTEIN VARIANTS HAVING MODIFIED IMMUNOGENECITY[2003/06]
French:PRODUCTION ET UTILISATION DE VARIANTS DE PROTEINES AYANT UNE IMMUNOGENICITE MODIFIEE[2003/06]
Entry into regional phase28.11.2002National basic fee paid 
20.12.2002Designation fee(s) paid 
20.12.2002Examination fee paid 
Examination procedure27.11.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
20.12.2002Examination requested  [2003/10]
30.03.2006Despatch of a communication from the examining division (Time limit: M06)
11.10.2006Application deemed to be withdrawn, date of legal effect  [2007/14]
13.11.2006Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2007/14]
Fees paidRenewal fee
02.05.2003Renewal fee patent year 03
03.05.2004Renewal fee patent year 04
02.05.2005Renewal fee patent year 05
02.05.2006Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9203551  (BIOMAY BIOTECH PROD [AT]);
 [X]WO9210755  (NOVO NORDISK AS [DK]);
 [X]US5583046  (VALENTA RUDOLF [AT], et al);
 [X]US5648242  (VALENTA RUDOLF [AT], et al);
 [X]US5804201  (KING TE PIAO [US]);
 [X]WO9934826  (IMP COLLEGE INNOVATIONS LTD [GB], et al);
 [A]WO9938978  (UNIV ARKANSAS [US], et al);
 [X]WO9947680  (ALK ABELLO A S [DK], et al);
 [A]WO9953038  (GENENCOR INT [US]);
 [PX]WO0026230  (NOVO NORDISK AS [DK]);
 [XP]EP1033405  (CERES INC [US]);
 [E]WO0137147  (ALGONOMICS NV [BE], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.